ClinicalTrials.Veeva

Menu

Detection of COVID-19 (SARS-CoV-2) in the Semen of COVID+ Patients (Positive RT-PCR on a Nasopharyngeal Swab) (COVISPERM)

G

GCS Ramsay Santé pour l'Enseignement et la Recherche

Status

Completed

Conditions

COVID

Treatments

Diagnostic Test: diagnostic

Study type

Interventional

Funder types

Other

Identifiers

NCT04460534
2020-A01206-33

Details and patient eligibility

About

The objective of this study is to look for the presence of SARS-CoV-2 in the semen of patients diagnosed with COVID+ based on RT-PCR analysis of nasopharyngeal swabs.

Full description

This is a prospective monocentric, open-label, prospective study of male patients with CoV-2-SARS.

Enrollment

52 patients

Sex

Male

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male patient between the ages of 18 and 65 who has read and signed the consent form for participation in the study.
  • Outpatient or inpatient without signs of respiratory severity, likely to be mobile
  • Patient whose medical condition warrants screening for COVID-19 by nasopharyngeal swab

Exclusion criteria

  • Patient under protective custody, guardianship or trusteeship
  • Patient not affiliated to the French social security system
  • Inability to provide the subject with informed information and/or written informed consent: dementia, psychosis, consciousness disorders, non-French speaking patient

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

52 participants in 1 patient group

COHORT
Experimental group
Description:
Cohort
Treatment:
Diagnostic Test: diagnostic

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems